Navigation Links
Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Date:5/1/2012

BLUE BELL, Pa., May 1, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,168,769, covering Inovio's SynCon® vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent granted to the Trustees of The University of Pennsylvania has been exclusively licensed to Inovio under its existing license agreement with the university. The patent includes claims that cover Inovio's synthetic consensus HPV antigens and DNA constructs and vaccines that include these antigens, including Inovio's cervical dysplasia/cancer vaccine, VGX-3100. This patent also covers methods of treating a patient using the SynCon® cervical dysplasia/cancer vaccine.

Dr. J. Joseph Kim, Inovio's president and CEO, said: "This additional patent grant bolsters the strong intellectual property portfolio around our SynCon synthetic vaccines. Because there is neither a therapeutic live virus vaccine nor non-replicating vaccine available for cervical dysplasias and cancers, Inovio's synthetic vaccine for these diseases answers an unmet need by providing a non-invasive and potentially more effective approach for treating women with this condition."

Inovio reported data demonstrating long-term durability of T cell immune responses of over two years in 87% (7 of 8) of evaluated patients following a fourth vaccination of VGX-3100. The data further highlighted the viability of using multiple booster vaccinations with a synthetic vaccine delivered using electroporation, in contrast to other non-replicating vaccine vectors that may induce unwanted immune responses against the vector after multiple vaccinations. Inovio's vaccine generated best-in-class T cell immune responses, which are widely believed to be im
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine
2. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
3. Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference
4. Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing
5. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
6. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
7. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
8. Inovio Pharmaceuticals Leadership for Life Sciences Recognized in the Philadelphia Region
9. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014  MedExpress Urgent Care, a national leader in delivering ... shots for ages four and up at each of its ... their flu shot early. According to the ... June, making late summer and early fall an ideal time ... President of Provider and Clinical Quality, Thomas Pangburn , ...
(Date:9/15/2014)... -- Chek Diagnostics, the U.S.-based manufacturer of both the ... products, has again been named to the Inc. ... America. The Inc. 5000 ranking is based ... earned its place on the list by growing its ... For Chek Diagnostics, who appears on the list ...
(Date:9/15/2014)... Following the decision ... or end market development and regulatory support ... APIs (active pharmaceutical ingredients) - including Atropine, ... Digoxin and Cimetropium Bromide - Alchem International ... maintain production and regulatory (Drug Master File) ...
Breaking Medicine Technology:MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap 2
(Date:9/15/2014)... September 15, 2014 Ondine Biomedical ... Loebel, its President and Chief Technology Officer, will ... Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. ... Brixen/Bressanone (Italy) from October 14-18, 2014 alongside the ... on October 13-14th, is an annual conference at ...
(Date:9/15/2014)... Octo Consulting Group, a leading provider ... federal government, today announced it is opening two ... to better serve existing and future federal government ... to the strong growth momentum of the company’s ... consulting, agile software development, data visualization, and data ...
(Date:9/15/2014)... approximately one out of every 40 individuals in the United ... muscular atrophy (SMA), a neurodegenerative disease that causes muscles to ... have made a recent breakthrough with the development of a ... of the disease. In April, a patent was filed for ... lab is using to fight SMA is to ,repress the ...
(Date:9/15/2014)... Ohio (PRWEB) September 15, 2014 In ... math and medicine often act conjointly to quantify, define ... industry has become an integral part of medical care. ... regularly reports the studies conducted by the non-profit Institute ... have consistently demonstrated that math can be much more ...
(Date:9/15/2014)... Dennis Thompson HealthDay Reporter ... severe respiratory virus believed to have sickened hundreds of ... spread to the Northeast, health officials report. The ... more than a dozen cases of infection with Enterovirus ... asthma. And on Saturday, the Connecticut Department of ...
Breaking Medicine News(10 mins):Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3
... and LONDON , July 16 Since January 2009, ... awards for its work in patient education and design. In ... four 2009 Communicator Awards from the International Academy ... the company was further notified of six more awards (two ...
... , , , HOUSTON, ... first and largest provider of outsourced implantable medical device management solutions to ... chief executive officer. The appointment follows the company,s tenth quarter of ... Partners , a leading private equity firm focused exclusively on healthcare. ...
... July 16 "We,ll quit before we practice government medicine" will be ... on July 17. , , The Association ... co-sponsor the protests at the local home office of each Congressman and ... run medicine. , , Taxpayers ...
... N.Y., July 16 In an order filed on July 13, ... District of Florida appointed as Lead Counsel to the Plaintiffs, Steering ... Esq., a partner in Parker Waichman Alonso LLP, and Scott Wm. ... , Co-Lead Counsel,s responsibility is to represent ...
... , , DENVER, July 16 ... named the best respiratory hospital in the nation by U.S. News ... "We are gratified that board-certified pulmonologists around the country continue to recognize ... care," said Michael Salem, MD, President and CEO of National Jewish Health. ...
... COLUMBUS, Ohio, July 16 Mettler-Toledo International Inc. (NYSE: MTD ... Company,s second-quarter results on Thursday, July 23, 2009 at 5:00 p.m. Eastern ... www.mt.com/investors on the Company,s website. A replay of the webcast ... , METTLER TOLEDO is a leading global supplier of precision ...
Cached Medicine News:Health News:MediciGlobal Achieves Record Number of Awards 2Health News:Access MediQuip Names Tim Hargarten Chief Executive Officer 2Health News:Access MediQuip Names Tim Hargarten Chief Executive Officer 3Health News:ANDRES F. ALONSO, ESQ., a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP, Was Appointed Co-Lead Counsel to the Plaintiffs' Steering Committee in the Denture Cream Products Liability Litigation, MDL 2051 2Health News:National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 2
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
... has the right product for any patient ... intubated patients to patients with tracheotomies. These ... and critical care applications., ,The Unti-Mist ... patients and staff members. This entire product ...
... Ulti-Mist™ HME product line has the right ... to adults and from intubated patients to ... humidification for both anesthesia and critical care ... provide maximum protection for patients and staff ...
... These hygroscopic condenser humidifiers (HCH) capture ... return them in the inspired gas. Small ... provide bacteriostatic and hygroscopic benefits. Depending on ... adult or small-volume model., ,The adult ...
Medicine Products: